TARSUS PHARMACEUTICALS, INC. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+49.1% +$185M
$562M
Current Assets↑+46.6% +$166M
$523M
Cash & Equivalents↑+93.7% +$89M
$184M
ST Investments↑+18.9% +$37M
$234M
Receivables↑+81.9% +$38M
$85M
Inventory↑+66.9% +$2M
$4M
Net PPE↑+404.1% +$9M
$12M
Intangibles↓-11.5% -$960K
$7M
Total Liabilities↑+43.5% +$66M
$219M
Current Liabilities↑+68.3% +$55M
$136M
Account Payables↑+74.0% +$7M
$16M
Long-Term Debt↑+0.8% +$593K
$72M
Stockholders Equity↑+53.0% +$119M
$343M
Retained Earnings↓-18.4% -$66M
$-427M
Operating Lease ROU Asset↑+1726.1% +$10M
$10M
Operating Lease Liability↑+1643.3% +$10M
$11M
Gross PP&E↑+220.8% +$9M
$14M
Accumulated Depreciation↑+6.2% +$122K
$2M
Inventory Raw Materials
$0
Inventory WIP↑+129.6% +$796K
$1M
Inventory Finished Goods↑+47.7% +$956K
$3M
Total Debt Carrying Amount↑+0.0% +$0
$75M
Contract Asset
—
Contract Liability
—
Contract Liability (Current)
—